Results 161 to 170 of about 4,351,772 (298)

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Critical roles of chronic BCR signaling in the differentiation of anergic B cells into age-associated B cells in aging and autoimmunity. [PDF]

Sci Adv
Imabayashi K, Yada Y, Kawata K, Yoshimura M, Iwasaki T, Baba A, Harada A, Akashi K, Niiro H, Baba Y.   +9 more
europepmc   +1 more source

Cytoplasmic inclusions and nuclear changes in cells infected with influenza-B viruses (Plate XII)

, 1968
Anna Porębska, H. G. Pereira, John A. Armstrong   +2 more
openalex   +1 more source

Glucose Inhibition of Adenylate Cyclase in Intact Cells of Escherichia coli B [PDF]

, 1974
Alan Peterkofsky, Celia Gazdar
openalex   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Comparison of the effect of iguratimod and hydroxychloroquine on regulatory B cells in the treatment of primary Sjögren's syndrome. [PDF]

Front Med (Lausanne)
Zou JM, Yang L, Luo JA, Ren Y, Li SY, Zhang Y, Dong JL, Deng DH, Ni YP, Li M, Yin XS, Yang J.   +11 more
europepmc   +1 more source

Tissue T and B cell infiltration of primary and metastatic cancer. [PDF]

, 1976
Gunnar Husby, Peter Hoagland, R. G. Strickland, Ralph C. Williams   +3 more
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Phosphatidylcholine-specific B cells are enriched among atypical CD11c^high and CD21^low memory B cells in antiphospholipid syndrome. [PDF]

Front Immunol
Nitschke E, Dang VD, Rincon-Arevalo H, Szelinski F, Ritter J, Schrezenmeier E, Alexander T, Le TA, Chen Y, Wiedemann A, Gonzalez JB, Lino AC, Stefanski AL, Dörner T.   +13 more
europepmc   +1 more source

Effect of Murine Cytomegalovirus on the in Vitro Responses of T and B Cells to Mitogens [PDF]

, 1976
MaryJane K. Selgrade, Aftab Ahmed, Kenneth W. Sell, M. Eric Gershwin, Alfred D. Steinberg   +4 more
openalex   +1 more source